ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Oncocyte Corporation

Oncocyte Corporation (OCX)

3.235
0.02
(0.78%)
Closed July 23 4:00PM
3.235
0.00
( 0.00% )
Pre Market: 4:11AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.235
Bid
1.29
Ask
3.39
Volume
-
0.00 Day's Range 0.00
2.08 52 Week Range 4.64
Market Cap
Previous Close
3.235
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
41,199
Shares Outstanding
13,364,637
Dividend Yield
-
PE Ratio
-1.50
Earnings Per Share (EPS)
-2.15
Revenue
7.27M
Net Profit
-28.72M

About Oncocyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers.... OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Headquarters
Irvine, California, USA
Founded
1970
Oncocyte Corporation is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker OCX. The last closing price for Oncocyte was $3.24. Over the last year, Oncocyte shares have traded in a share price range of $ 2.08 to $ 4.64.

Oncocyte currently has 13,364,637 shares outstanding. The market capitalization of Oncocyte is $43.23 million. Oncocyte has a price to earnings ratio (PE ratio) of -1.50.

OCX Latest News

MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode

HOLLAND, Mich., July 11, 2024 (GLOBE NEWSWIRE) -- MedTech Gurus, a leading podcast focused on the forefront of medical technology, featured Oncocyte Corporation (NASDAQ: OCX) CEO Josh Riggs in...

Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move

NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leader within the financial markets and news community, announces the release of an article highlighting the precision diagnostics...

Oncocyte Appoints Andrea James as Chief Financial Officer

IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea...

Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Oncocyte’s (Nasdaq: OCX) VitaGraft Kidney™ diagnostic test for transplant monitoring has shown promising results in a Phase 2 clinical trial...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.055-1.67173252283.293.393.1188743.21028866CS
40.68526.8627450982.553.47992.55685373.11023072CS
120.73529.42.53.47992.48411992.97227329CS
26-0.065-1.96969696973.33.47992.285468502.83550618CS
52-1.135-25.97254004584.374.642.08355953.06682966CS
156-103.365-96.9652908068106.6109.62.0831006430.50785582CS
260-66.565-95.365329512969.81252.0834300744.32181193CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 2.03
(97.09%)
596.27k
ALLRAllarity Therapeutics Inc
$ 0.2997
(80.00%)
6.85M
RGCRegencell Bioscience Holdings Ltd
$ 23.00
(53.74%)
62.72k
NIVFNewGenIvf Group Ltd
$ 1.09
(25.16%)
466.15k
KITTNauticus Robotics Inc
$ 3.96
(21.10%)
48.34k
CONNConns Inc
$ 0.261
(-48.52%)
38.32k
VSTMVerastem Inc
$ 2.80
(-22.01%)
1.53k
ATPCAgape ATP Corporation
$ 0.1704
(-20.74%)
43.53k
ALPPAlpine 4 Holdings Inc
$ 0.4899
(-18.34%)
15.57k
SLRXSalarius Pharmaceuticals Inc
$ 2.16
(-17.24%)
4.6k
ALLRAllarity Therapeutics Inc
$ 0.2997
(80.00%)
6.85M
SLNASelina Hospitality PLC
$ 0.0276
(6.15%)
2.44M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 11.57
(-15.55%)
703.91k
NUZENuZee Inc
$ 2.03
(97.09%)
597.16k
NIVFNewGenIvf Group Ltd
$ 1.09
(25.16%)
466.15k

Discussion

View Full Feed
chaostrader chaostrader 6 minutes ago
When will PDMI have a business operation
PDMI
fuagf fuagf 8 minutes ago
Yep, was good to see back when Biden finally got older Americans
something like we oldies in Australia have had the benefit of for years.
Handlamera Handlamera 8 minutes ago
Thank you for info Laxmi!
I really hope that you now can give yourself and your heart time to get well!
J
ITUP
Margin Buu Margin Buu 13 minutes ago
One of the biggest FUD tactics has been around the timeframe of this approval. There have been 1000 posts by nefarious actors just trying to convince us that the 150-day review pathway (requested by the company) was in business days when the review clock has always been CALENDAR DAYS. Not only is t
NWBO
chicks0123 chicks0123 15 minutes ago
Good morning CLNVERS
CLNV
urge2surge urge2surge 17 minutes ago
Copied and posted word for word.
FDCT
dirkv dirkv 18 minutes ago
Theravet (BE0974387194) Euronext Growth Paris et Bruxelles : 0.278
52w: 0.278 – 2.4
https://www.thera.vet/en/home

https://www.theravet-finances.com/images/202404_Theravet_Company_Presentation_Competition_Sport_Horses.pdf

their products:
https://bioc
dirkv dirkv 18 minutes ago
Theravet (BE0974387194) Euronext Growth Paris et Bruxelles : 0.278
52w: 0.278 – 2.4
https://www.thera.vet/en/home

https://www.theravet-finances.com/images/202404_Theravet_Company_Presentation_Competition_Sport_Horses.pdf

their products:
https://bioc
manfromjax manfromjax 20 minutes ago
WOW, am I going to be happy that I picked up 2000 more shares of ALLR at .17!!!
average is now .32.
Was up to .30 as I sit here in Riga Latvia.
ALLR
ShadowDiviner72 ShadowDiviner72 22 minutes ago
Shorts can say whatever they want, but why is the cost to borrow fee decreasing rapidly?

In 10 trading days from 96% to 9%

Apparently the demand for short shares is decreasing quickly
MAXN
MrLWLG101 MrLWLG101 24 minutes ago
The news about the appointment of Yves LeMaitre, a renowned and respected figure in the industry and business, acts as a magnet for short-sellers. I see this more in terms of "defamation and slander" against him and the entire BOD of LWLG, without thorough reasons and evidence. The moderators should
LWLG
SkeBallLarry SkeBallLarry 25 minutes ago
Graceland (from The Concert in Hyde Park >

https://youtu.be/0VTcBO4q5kY
SkeBallLarry SkeBallLarry 25 minutes ago
Graceland (from The Concert in Hyde Park >

https://youtu.be/0VTcBO4q5kY
SkeBallLarry SkeBallLarry 26 minutes ago
BreakTime ~ Graceland (from The Concert in Hyde Park >

https://youtu.be/0VTcBO4q5kY
palaypu0406 palaypu0406 26 minutes ago
whenever large wires that too international wires transfer in, or anytime if there is a larger inward (even domestic) with regular balances not anywhere near to the size of the funds coming in, bank does keep the funds on hold and release within the defined date.
ITUP
1hunglo 1hunglo 28 minutes ago
AGREED.
RDGL
palaypu0406 palaypu0406 29 minutes ago
Dear Snow and all (I am addressing Snow first as he is the eldest among the group),
I am very happy to share that we have money availability on the 7/29/2024) -- This is one year of burn -- facing so many challenges, insults, humiliation and spits on face. Despite that - we never let our spi
ITUP
Margin Buu Margin Buu 34 minutes ago
Thanks for pointing out Leg-ends hypocrisy. He’s a spreader of FUD and not very good at it.
NWBO
Jack Torrance Jack Torrance 37 minutes ago
I personally think 80%.
MNMD
CaptainObvious CaptainObvious 41 minutes ago
"The reality about this stock is nobody knows anything....

...something I will bet a lot on is that the stock will not get above $1"
NWBO
Capt_Smith77 Capt_Smith77 1 hour ago
I'll believe in their backing of G42 when it doesn't amount to diluting shareholders, and there's an actual appreciation in the stock price. To date, the company's financing has done nothing but reduce shareholder value.

Now on a more positive note, at least we haven't seen any recen
VRSSF